Evidence map›Paper›PMID 36568836›Full record

ReviewThe Yale journal of biology and medicine2022

Gut Microbiota Modulation and Prevention of Dysbiosis as an Alternative Approach to Antimicrobial Resistance: A Narrative Review.

Rafail Matzaras, Anna Nikopoulou, Efthimia Protonotariou, Eirini Christaki

Open access · greenAbstract readReview
In one paragraph

Review in The Yale journal of biology and medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Review
  7. Review
  8. Mapping 25 years of research on gut microbiota and antibiotic resistance: bibliometric insights and future directions.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Non-invasive treatment ofFrontiers in microbiology · 2025
    Article
  17. Article
  18. Medicinal Cannabis and the Intestinal Microbiome.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Rafail MatzarasInfectious Diseases Unit, Department of Medicine, University General Hospital of Ioannina, University of Ioannina, Ioannina, Greece.
Anna NikopoulouDepartment of Internal Medicine, G. Papanikolaou General Hospital of Thessaloniki, Thessaloniki, Greece.
Efthimia ProtonotariouDepartment of Microbiology, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Eirini ChristakiInfectious Diseases Unit, Department of Medicine, University General Hospital of Ioannina, University of Ioannina, Ioannina, Greece.
Aristotle University of Thessaloniki · GRG. Papanikolaou General Hospital · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gastrointestinal MicrobiomeProbioticsAnti-Bacterial AgentsDrug Resistance, BacterialDysbiosisFecal Microbiota TransplantationHumansAnti-Bacterial Agentsantimicrobial resistanceantimicrobial stewardshipbeta-lactamasescharcoal agentdysbiosisfecal bacteriotherapyfecal microbiota transplantationgut microbiotaMicrobiomemultidrug-resistant organismsprebioticsprobioticsresistome

Identifiers

PMID36568836
PMCPMC9765331
OpenAlexW4312211920

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.